Dr. Tara Frenkl is a recognized leader in pharmaceutical development and strategic innovation, bringing over two decades of experience across global drug development and commercialization. As SVP of Global Medical and Evidence at Bayer, she oversees integrated medical strategy and evidence generation, driving transformative outcomes through real-world evidence studies, data-driven insights, and scientific communication and education. Dr. Frenkl also serves on the FDA Oncology Drugs Advisory Committee (2024–2027) as the pharmaceutical industry representative. A board-certified urologist and former academic clinician, she blends deep clinical research and therapeutic expertise with a passion for patient-centered innovation. Committed to fostering collaboration across industry, academia, and public health, Dr. Frenkl’s career exemplifies the fusion of science, strategy, and partnership.